The invention provides novel compounds of formulae I and II:
that are monoamine oxidase-B inhibitors, which can be useful in treating obesity, diabetes, and/or cardiometabolic disorders (e.g., hypertension, dyslipidemias, high blood pressure, and insulin resistance).
该发明提供公式I和II的新化合物:它们是单胺氧化酶-B
抑制剂,可用于治疗肥胖症,糖尿病和/或心血管代谢失调(例如高血压,血脂异常,高血压和
胰岛素抵抗)。